Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

635 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease.
van der Harst P, Wagenaar LJ, Buikema H, Voors AA, Plokker HW, Morshuis WJ, Six AJ, Boonstra PW, Nickenig G, Wassmann S, van Veldhuisen DJ, van Gilst WH. van der Harst P, et al. Among authors: van gilst wh, van veldhuisen dj. Am J Cardiol. 2005 Nov 15;96(10):1361-4. doi: 10.1016/j.amjcard.2005.07.052. Epub 2005 Sep 19. Am J Cardiol. 2005. PMID: 16275178 Clinical Trial.
Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P, Voors AA, Volbeda M, Buikema H, van Veldhuisen DJ, van Gilst WH. van der Harst P, et al. Among authors: van gilst wh, van veldhuisen dj. Am J Cardiol. 2006 Jun 15;97(12):1697-701. doi: 10.1016/j.amjcard.2006.01.030. Epub 2006 Apr 21. Am J Cardiol. 2006. PMID: 16765116
Effects of C-reactive protein and cholesterol on responsiveness in vitro of the internal thoracic artery to angiotensin II in patients having coronary artery bypass grafting.
van der Harst P, Asselbergs FW, Buikema H, Voors AA, van Veldhuisen DJ, van Gilst WH. van der Harst P, et al. Among authors: van gilst wh, van veldhuisen dj. Am J Cardiol. 2006 Sep 15;98(6):751-3. doi: 10.1016/j.amjcard.2006.04.010. Epub 2006 Jul 26. Am J Cardiol. 2006. PMID: 16950177
Telomere length of circulating leukocytes is decreased in patients with chronic heart failure.
van der Harst P, van der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ, van Gilst WH, van Veldhuisen DJ; MERIT-HF Study Group. van der Harst P, et al. Among authors: van gilst wh, van der steege g, van veldhuisen dj. J Am Coll Cardiol. 2007 Apr 3;49(13):1459-64. doi: 10.1016/j.jacc.2007.01.027. Epub 2007 Mar 21. J Am Coll Cardiol. 2007. PMID: 17397675 Free article.
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, Koster J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Westenbrink BD, et al. Among authors: van gilst wh, van der harst p, van der meer p, van veldhuisen dj. Eur Heart J. 2007 Aug;28(16):2018-27. doi: 10.1093/eurheartj/ehm177. Epub 2007 Jun 17. Eur Heart J. 2007. PMID: 17576662
Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).
van der Harst P, Slart RH, Tio RA, Dunselman PH, Willemsen AT, van den Heuvel AF, Voors AA, van Veldhuisen DJ; CORONA Study Group. van der Harst P, et al. Among authors: van den heuvel af, van veldhuisen dj. Am J Cardiol. 2010 Feb 15;105(4):517-21. doi: 10.1016/j.amjcard.2009.10.021. Epub 2010 Jan 5. Am J Cardiol. 2010. PMID: 20152247 Clinical Trial.
Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
Lexis CP, van der Horst IC, Lipsic E, van der Harst P, van der Horst-Schrivers AN, Wolffenbuttel BH, de Boer RA, van Rossum AC, van Veldhuisen DJ, de Smet BJ; GIPS-III Investigators. Lexis CP, et al. Among authors: van rossum ac, van der horst ic, van der horst schrivers an, van der harst p, van veldhuisen dj. Cardiovasc Drugs Ther. 2012 Oct;26(5):417-26. doi: 10.1007/s10557-012-6413-1. Cardiovasc Drugs Ther. 2012. PMID: 22968678 Free PMC article. Clinical Trial.
635 results